Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
mercoledì, ottobre 28
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Bluejay Diagnostics Inc
BJDX
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.6000
0.0229
3.97%
Ult. Agg.: Oct 28, 8:57 AM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Bluejay Diagnostics Financials
Bluejay Diagnostics (BJDX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Bluejay Diagnostics Q2 EPS $(1.12) Up From $(5.64) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.12) per share. This is a 80.14 percent increase over losses of $(5.64) per share from the same period last year.
Benzinga Newsdesk
PRO
Bluejay Diagnostics Q1 EPS $(1.95) Up From $(13.48) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.95) per share. This is a 85.53 percent increase over losses of $(13.48) per share from the same period last year.
Benzinga Newsdesk
PRO
Bluejay Diagnostics Q2 EPS $(1.41) Up From $(256.16) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.41) per share. This is a 99.45 percent increase over losses of $(256.16) per share from the same period last year.
Benzinga Newsdesk
PRO
Bluejay Diagnostics Q1 EPS $(3.37) Up From $(394.76) YoY
Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(3.37) per share. This is a 99.15 percent increase over losses of $(394.76) per share from the same period last year.
Benzinga Newsdesk
Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings
Avi Kapoor
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March
Avi Kapoor
